DFTX compared with TLRY: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

TLRYTilray Brands, Inc.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

TLRYTilray Brands, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

Q1 FY26±12.9%▲+0.93%×0.07

Jan 12 '26—▲+0.29%—

TLRY2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 8 '26±9.3%▼−3.36%×0.37

Q1 FY27—▲+5.26%—

= impliedDFTX realized, solidTLRY realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedspan: DFTX 207d · TLRY 70dSource: market data

DFTXDefinium Therapeutics, Inc.

30.34▼−7.21%· post 30.39

Mkt cap$4.4BRevenue—Revenue—

TLRYTilray Brands, Inc.

2.81▼−5.07%· post 2.78

ClosedNov 5 '26

Mkt cap$437.5MRevenue$257MQ1 FY27Revenue$915MFY26

Compare

ClosedNov 5 '26

DFTXDefinium Therapeutics, Inc.

TLRYTilray Brands, Inc.

30.34▼−7.21%post 30.39

Price

2.81▼−5.07%post 2.78

$4.4B

Mkt cap

$437.5M

—

Revenue

$257MQ1 FY27

—

Revenue

$915MFY26

DFTX30.34▼−7.21%vsTLRY2.81▼−5.07%ClosedNov 5 '26